We evaluated predictors of increased periprocedural creatine kinase-MB isoenzyme levels after implantation of sirolimus-eluting stents with an intent to fully cover the diseased segment. The total stent length per patient (predisposing factor) and elective use of glycoprotein IIb/IIIa (protective factor) were independent predictors of increased creatine kinase-MB isoenzyme levels. (C)2004 by Excerpta Medica, Inc.
Stankovic, G., Chieffo, A., Iakovou, I., Orlic, D., Corvaja, N., Sangiorgi, G., et al. (2004). Creatine kinase-myocardial band isoenzyme elevation after percutaneous coronary interventions using sirolimus-eluting stents. THE AMERICAN JOURNAL OF CARDIOLOGY, 93(11), 1397-1401 [10.1016/j.amjcard.2004.02.039].
Creatine kinase-myocardial band isoenzyme elevation after percutaneous coronary interventions using sirolimus-eluting stents
Sangiorgi G.;
2004-01-01
Abstract
We evaluated predictors of increased periprocedural creatine kinase-MB isoenzyme levels after implantation of sirolimus-eluting stents with an intent to fully cover the diseased segment. The total stent length per patient (predisposing factor) and elective use of glycoprotein IIb/IIIa (protective factor) were independent predictors of increased creatine kinase-MB isoenzyme levels. (C)2004 by Excerpta Medica, Inc.| File | Dimensione | Formato | |
|---|---|---|---|
|
2004-15165923-AJC-CK after Sir-DES.pdf
solo utenti autorizzati
Licenza:
Copyright dell'editore
Dimensione
83.96 kB
Formato
Adobe PDF
|
83.96 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
